| Biological activity of a stable 6-aryl-2-benzoyl-pyridine colchicine-binding site inhibitor, 60c, in metastatic, triple-negative breast cancer D Oluwalana, KL Adeleye, RI Krutilina, H Chen, H Playa, S Deng, ... Cancer Letters, 217011, 2024 | | 2024 |
| A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides MZ Ali, TS Dutt, A MacNeill, A Walz, J Patterson, C Pearce, H Lam, ... eLife 13, 2024 | | 2024 |
| The atypical antipsychotic aripiprazole alters the outcome of disseminated Candida albicans infections P Reitler, J Regan, C DeJarnette, A Srivastava, J Carnahan, KM Tucker, ... bioRxiv, 2024 | | 2024 |
| Pharmacokinetics and Pharmacodynamics of Therapeutic Proteins and Nucleic Acids B Meibohm Pharmaceutical Biotechnology: Fundamentals and Applications, 119-152, 2024 | | 2024 |
| Development of 2nd generation aminomethyl spectinomycins that overcome native efflux in Mycobacterium abscessus GA Phelps, MN Cheramie, DM Fernando, P Selchow, CJ Meyer, ... Proceedings of the National Academy of Sciences 121 (2), e2314101120, 2024 | 2 | 2024 |
| Prolonged glucocorticoid treatment in ARDS: Pathobiological rationale and pharmacological principles G Umberto Meduri, M Confalonieri, D Chaudhuri, B Rochwerg, ... Handbook of Stress Series Volume 5 5, 289-323, 2024 | | 2024 |
| Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis AA Bauman, JP Sarathy, F Kaya, LM Massoudi, MS Scherman, ... bioRxiv, 2024.05. 13.593953, 2024 | | 2024 |
| Prolonged glucocorticoid treatment in ARDS: Pathobiological rationale and pharmacological principles GU Meduri, M Confalonieri, D Chaudhuri, B Rochwerg, B Meibohm Stress: Immunology and Inflammation, 289-324. e1, 2024 | 1 | 2024 |
| ROLE OF DEVICE CHARACTERISTICS ON THE AERODYNAMIC PARTICLE SIZE DISTRIBUTION OF TIGECYCLINE DRY POWDER AEROSOLS S Maloney, L Levin, C Strickland, I Alshiraihi, JM Gonzalez, A Singh, ... JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 36 (6), A26-A26, 2023 | | 2023 |
| A NEW PASSIVE INHALATION CHAMBER FOR IN VIVO PRECLINICAL TESTING OF DRY POWDER INHALATION FORMULATIONS J Mariner-Gonzalez, I Alshiraihi, H Lam, S Maloney, A Singh, H Park, ... JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 36 (6), A15-A16, 2023 | | 2023 |
| A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides TS Dutt, A MacNeil, A Walz, J Patterson, C Pearce, H Lam, R Lee, J Liu, ... | | 2023 |
| Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models SE Maloney, IE Stewart, JB Mecham, M Gonzalez-Juarrero, B Meibohm, ... JoVE (Journal of Visualized Experiments), e65756, 2023 | | 2023 |
| Disposable Dosators Intended for Dry Powder Delivery to Mice. SE Maloney, IE Stewart, JB Mecham, M Gonzalez-Juarrero, B Meibohm, ... Journal of Visualized Experiments: Jove, 2023 | 1 | 2023 |
| TNX-1500, a crystallizable fragment–modified anti-CD154 antibody, prolongs nonhuman primate cardiac allograft survival S Miura, ZA Habibabady, F Pollok, M Ma, IA Rosales, K Kinoshita, S Pratts, ... American Journal of Transplantation 23 (8), 1182-1193, 2023 | 5 | 2023 |
| TNX-1500, a crystallizable fragment–modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival G Lassiter, R Otsuka, T Hirose, I Rosales, A Karadagi, T Tomosugi, ... American Journal of Transplantation 23 (8), 1171-1181, 2023 | 8 | 2023 |
| Use of machine learning for dosage individualization of vancomycin in neonates BH Tang, JY Zhang, K Allegaert, GX Hao, BF Yao, S Leroux, AH Thomson, ... Clinical pharmacokinetics 62 (8), 1105-1116, 2023 | 6 | 2023 |
| Clinical and translational pharmacology considerations for anti-infectives approved under the FDA animal rule ZH Temrikar, JE Golden, CB Jonsson, B Meibohm Clinical Pharmacokinetics 62 (7), 943-953, 2023 | 2 | 2023 |
| Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics KR Parmar, PB Lukka, S Wagh, ZH Temrikar, J Liu, RE Lee, M Braunstein, ... Pharmaceutics 15 (6), 1759, 2023 | 1 | 2023 |
| Barriers to global pharmacometrics: educational challenges and opportunities across the globe R Michelet, LBS Aulin, JM Borghardt, T Dalla Costa, P Denti, M Ibarra, ... CPT: Pharmacometrics & Systems Pharmacology 12 (6), 743, 2023 | 3 | 2023 |
| The inducible prostaglandin E synthase (mPGES-1) in neuroinflammatory disorders MN Sluter, Q Li, N Yasmen, Y Chen, L Li, R Hou, Y Yu, CY Yang, ... Experimental Biology and Medicine 248 (9), 811-819, 2023 | 1 | 2023 |
